
Monday, September 13, 2010
Embassy Suites, Chesterbrook, Pennsylvania (directions)

|
Aviana Molecular Technologies
Development stage company

About

|
Aviana Molecular Technologies (AMT) is a development stage company focused on marketing a new generation of innovative, highly sensitive and specific, State-of-the-Art Biosensors specifically targeting point-of-care (POC) diagnostic products for human healthcare and veterinary medicine. AMT's focus is to identify areas in POC with high unmet needs in the US and around the world, where POC diagnosis can make a difference in human health. AMT's biosensor technology is based on an innovative and proprietary adaptation of the commonly used surface acoustic wave sensors (SAW) with critical changes that make this technology applicable as a biosensor. Further innovation allows AMT's biosensor to be used to diagnose multiple diseases and biomarkers in one chip using an entirely electronics-based system for readouts.

3 Major Issues

|
- Market Changes in the New Health Care System: With the onset of all the new insured, there will not be enough physicians to see all new patients, most likely expanded through the currently established Federal Community Health Centers. How will the new health care system respond and how can AMT, who will create a CLIA waived, easy to use, sensitive POC test fit in this new model? Will near-patient diagnosis provide an important growth in this new market concept?
- How should AMT’s POC test be priced (lab tests range from $150-$170 for similar tests, reimbursement is between $100-$130) and how will AMT obtain reimbursement for a new POC system, which is a multiplexed POC diagnostic device with the potential sensitivity of a lab based test?
- How will the distribution of near-patient diagnostics change as a result of the ongoing consolidation in the health care system?

Program:

|
6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)
8:00 - Vanaja Ragavan MD, CEO and Founder of AMT will deliver the Company's "Elevator" Pitch to the Group
8:20 - A Panel will address 3 Major Issues for the Company
9:00 - Open discussion: members and guests
<Top of the page>
|
 |
 |

Slides
None available at this time

Audio
None available at this time

Video
None available at this time

Webcast
Aviana Webcast 09/13/10

|

|
|